![Xiayang Qiu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiayang Qiu
Directeur Général chez
Regor Therapeutics Group
Health Technology
Profil
Xiayang Qiu is the founder and Chief Executive Officer of QILU Regor Therapeutics, Inc., founded in 2018.
He is also the founder and Chief Executive Officer of Regor Therapeutics Group, founded in 2018.
Postes actifs de Xiayang Qiu
| Sociétés | Poste | Début |
|---|---|---|
Regor Therapeutics Group
 Regor Therapeutics Group BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops medicines for oncology, metabolism and auto-immunity | Directeur Général | 01/07/2018 |
QILU Regor Therapeutics, Inc. | Directeur Général | 01/01/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Regor Therapeutics Group
Regor Therapeutics Group BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops medicines for oncology, metabolism and auto-immunity | Health Technology |
QILU Regor Therapeutics, Inc. |
